One of the specific inhibitors of calmodulin action, trifluoperazine, blocked the stimulating action of insulin on 2-deoxyglucose uptake and glucose metabolism. The inhibitory effect of insulin on lipolysis was not altered by the drug. The active (insulin-stimulated) state and the basal state of lipogenesis were inhibited half-maximally at 80 and 550 ,LM trifluoperazine, respectively. 2-Deoxyglucose uptake was inhibited half-maximally at a trifluoperazine concentration of 70 iM. Other less potent calmodulin inhibitors also inhibited glucose metabolism in fat cells but in a nonspecific manner. The inhibition was noncompetitive and was not altered in Ca2+-free medium. The stimulating activity of wheat germ agglutinin and of sodium vanadate were also inhibited by trifluoperazine. The dose-dependent inhibitions were indistinguishable whether the active (stimulated) state was produced by insulin, wheat germ agglutinin, or vanadate. The data indicate that a late event in the sequence that ultimately leads to enhanced glucose transport activity in fat cells is specifically inhibited by trifluoperazine. The possible involvement of calmodulin or another related Ca2+-dependent regulatory protein in the exocytic (fusion) reaction that recruits glucose-transport activity from storage sites to the plasma membranes is discussed.
quires millimolar concentrations of calcium (6) , whereas the free Ca2+ concentration in cells is 0.1-1 ,uM (7) . It is therefore conceivable that additional factors play a role in the regulation of fusion processes. Although an insulin-dependent increase in intracellular Ca2+ level has been suggested (reviewed in refs. 8 and 9) , this in itself does not seem to be sufficient to produce insulin-like effects, because an artificial increase in intracellular calcium level does not mimic insulin in fat cells (10, 11) . In recent years it has become apparent that many of the biological effects of Ca2+ are directed to specific regions or to specific activities within the cell by the Ca2+-dependent regulatory protein calmodulin (for general reviews see refs. 12 and 13). Calmodulin is therefore seen as directing the effect of a general increase in, for example, cytoplasmic Ca2+ to certain molecules or activities within the cell. Other calcium-binding proteins, which are less characterized than calmodulin, are known to exist in various mammalian tissues (12, 13) . Some may have conformational homologies to calmodulin because they also bind to fluphenazine affinity columns in a calcium-dependent manner (14) . Calmodulin has not been implicated so far in the mechanism of exocytosis. In contrast, synexin, a calcium-binding protein presumed to have a major role in exocytosis of chromaffin cells (reviewed in ref. 15 
327
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" port was only slightly affected by the latter TFP concentration. Thus, the drug inhibits the stimulatory action of insulin on hexose transport.
Type of TFP Inhibition. The dose-dependent inhibition of the active state of lipogenesis (v; -Vb) as a function of TFP concentration was compared after stimulation with low (0.017 nM) and high (17 nM) concentrations of insulin with that produced by wheat germ agglutinin (WGA) (21, 22) Fig. 1; Table 1 ). Other calmodulin inhibitors, however, are also expected to inhibit lipogenesis (at least in a nonspecific manner), and in a reasonable order to their relative affinities for calmodulin, in in vitro systems. Fig. 4 indicates that except for fluoperazine, which is less potent in the fat cell than expected, other drugs inhibit this process with approximately the same efficacy that they inhibit calmodulin-activated phosphodiesterase in vitro (26, 27) . The activity sequence is TFP > W13 > propranolol > W12 > promethazine (values derived from Figs. 3 and 4) . In the case of W13 and its dechlorinated derivative W12, these compounds are nearly identical in their hydrophobicity (and accordingly in their nonspecific action; ref. 28 ). W13 and W12, however, inhibit calmodulin-activated phosphodiesterase with IC50 values of 68 and 260 ,uM, respectively (27) . In agreement with those values, W13 is about 3 times more potent than W12 in inhibiting lipogenesis (Fig. 4) . Table 2 ). In contrast to the inhibitory effect of the drug in blocking insulin-mediated lipogenesis, TFP did not affect at all the ability of insulin to antagonize lipolysis ( 
DISCUSSION
The present study shows that TFP, an inhibitor that binds to calmodulin and inhibits calmodulin-dependent activation of enzymes (12, 13, 29) , blocks the stimulating effect of insulin on hexose transport and glucose metabolism. Kinetic analysis of the inhibition revealed that this drug inhibits the active state of this process with ID50 values of 70-90 p.M. In contrast, the basal (unstimulated) state is half maximally inhibited at 550 ;LM TFP.
The preferential inhibitory effect of TFP toward the active state seems to be unique to this drug. Among a large number of other low molecular weight substances, some were totally ineffective, whereas others were equally effective in inhibiting both the basal and the stimulated state. Further studies have revealed that the antilipolytic activity of insulin (both the extent and dose dependency) has not been altered by the drug, thus indicating that the binding of the hormone, the putative cytoplasmic second messenger(s), as well as all biochemical pathways that lead to lipolysis and antilipolysis in adipocytes are not affected by TFP. Inhibition of lipogenesis is noncompetitive and is at the same site or posterior to that modulated by vanadate ion (24, 25) .
The results are most compatible with a role for calmodulin or another related CDR in one of the events that finally leads to insulin-mediated increase in glucose-transport activity.
Because the affinity of the drug to those proteins is calcium dependent (14, 29) , the active state is associated with higher proportions of Ca2+/CDR. This is in agreement with many studies that postulate an insulin-dependent increase in cytoplasmic Ca2+ (reviewed in refs. 8, 30, and 31) .
TFP may possibly inhibit the endocytic and exocytic (fusion) reactions that lead to the recruitment of glucose-transport activity from the storage sites to the plasma membrane (1) (2) (3) (4) . By analogy to the chromaffin cells (reviewed in ref. 15), the fat cell system is postulated also to contain an essential CDR that would enable aggregation and fusion at low concentrations of calcium.
Creutz has shown that the addition of cis-unsaturated fatty acids to chromaffin granules, previously aggregated by synexin, led to fusion in the region of contact formed by synexin with the subsequent formation of larger vesicles (32) . The addition of cis-unsaturated fatty acids to intact adipocytes at 370C has been found to partially stimulate lipogenesis. The same treatment greatly increased (12-to 20 -fold) the ability of the cells to bind 45Ca2+ (unpublished observations). It is concluded that cis-unsaturated fatty acids induce a gross change in lipid organization, leading to a new calcium-binding phase, which favors translocation of glucose-transport activity. Taken together, the experimental evidence from this laboratory and the analogy to the in vitro fusion of the chromaffin granules (15, 32) suggest that CDR, Ca2+, and free cis-unsaturated fatty acids present in the cytoplasm are the prerequisite components for the insulin-dependent endocytic and exocytic reactions that lead to translocation of glucose-transport activity.
Alternatively, CDR may participate in phosphorylation and dephosphorylation of enzymes. Calmodulin was shown to alter the activity of several protein kinases (33) (34) (35) (36) and, as proposed by Denton et al. (37) , activation of membrane-associated insulin-dependent protein kinase may be an essen- Lipolysis was carried out for 3 hr. TFP was added to the cell suspension 10 min before the addition of the hormones. tial event in metabolic regulation by insulin. Recent data from different laboratories have indicated that the B-subunit of the insulin receptor can itself undergo an insulin-dependent phosphorylation in several target cells (38, 39) as well as in a cell-free system (40, 41) . Although it would appear that the insulin-dependent receptor-mediated protein kinase activity is insufficient to directly regulate metabolism, a cascade mechanism that would amplify this signal is possible. Calmodulin may participate in such a cascade.
It is somewhat surprising that among the phenothiazines and the naphthalene sulfonamides only TFP inhibits the active state of hexose transport and lipogenesis in a specific manner and at a relatively high concentration. TFP, however, is the most potent inhibitor of calmodulin (and probably of other related CDR) as judged by its anticalmodulin activity in enzymic (cell-free) systems (summarized in ref. 26) . The relatively high concentration of TFP needed to inhibit this process probably reflects a low ratio of Ca2 /CDR associated with the active state. The insulin-dependent increase in calcium is believed to originate from internal stores ( Fig.  2B ; see ref. 8 for review). It is therefore logical to assume that at steady state, the increased intracellular Ca2+ concentration in the activated cells is lower than that in most exocytic systems, in which the increase in cytoplasmic Ca2+ originates from the medium. Higher concentrations of TFP are therefore required to block glucose entry and metabolism in adipocytes.
